(1)
Commentary on “Preventive Percutaneous Coronary Intervention Versus Optimal Medical Therapy Alone for the Treatment of Vulnerable Atherosclerotic Coronary Plaques (PREVENT): A Multicenter, Open-Label, Randomized Controlled trial.” Bleeding Thromb Vascul Biol 2024, 3 (2). https://doi.org/10.4081/btvb.2024.141.